7 May 2019 | Berlin, Germany

Agenda

Tuesday
7 May 2019
08:15 – 13:00
BIONNALE Science & Sights Tour

Get in touch with the life sciences in the German Capital Region and see the city during your stay! This year, the tour will take you to Berlin-Buch, one of the most forward thinking biomedical hubs in Germany. (For delegates from outside HealthCapital Berlin-Brandenburg only).

The tour is booked out! If you want to be put on the waiting list please contact Mr. Julian Ramirez via julian.ramirez@berlin-partner.de

13:30 – 15:30
Großer Vortragssaal - basement
Biotech / Pharma Session - in cooperation with vfa bio

Advanced Therapy Medicinal Products (ATMPs): Status quo and future aspects

Introduction: ATMPs - an overview
Dr. Sabine Sydow, vfa bio


Guided talk with SMEs: Challenges and solutions in developing and bringing ATMP to the market

Prof. Dr. Regine Heilbronn, Charité – Universitätsmedizin Berlin
Dr. Elisa Kieback, T-Knife
Dr. Steffen Hennig, Therycell GmbH
Dr. Giulietta Roël, CO.DON AG

Experiences from academia and industry: ATMPs today and tomorrow

CAR-T-cells in oncology: Benefit, opportunities and challenges
Dr. Katja Schmidt, Novartis AG

ATMP Manufacturing as CMO: Challenges to deliver New Therapies to Patients
Dr. Christoph Prinz, Apceth Biopharma GmbH

BeCAT: bringing ATMP from the lab to clinical application

Dr. Andy Römhild, Berlin Center for Advanced Therapies (BeCAT)

    Questions & Answers

    Conference
    13:30 – 17:30
    Kleiner Vortragssaal - basement
    Cooperation Track

    Companies, universities and research institutions are invited to apply for a short presentation.

    The Cooperation Track offers an opportunity to companies and scientific institutions  to introduce themselves in a five minute pitch, to make themselves known to a broad audience and to network. The focus is on the biotech, medtech, pharmaceutical and digital health sectors.

    NetPhaSol - Network for Pharma Solutions

    Host: Dr. Marc Hovestädt - Surflay Nanotec GmbH
    EPO-Berlin-Buch GmbH
    Chiracon GmbH
    BioNukleo GmbH
    BioVariance GmbH
    NMI TT Pharmaservices
    Fraunhofer Institute for Applied Polymer Research IAP
    Charité-Universitätsmedizin Berlin Department of Radiology
    2bind GmbH

    Biotech | Pharma

    Host: Ute Mercker - Investment Director IBB Beteiligungsgesellschaft
    PolyAn GmbH
    Central BioHub GmbH
    CILcare Inc.
    Metanomics Health GmbH
    GxP brain GmbH
    LabTwin GmbH
    Vivomicx BV
    PerioTrap Pharmaceuticals GmbH
    Knauer Wissenschaftliche Geräte GmbH

    Academic | Transfer | International Networks

    Host: Volker Erb - Berlin Partner für Wirtschaft und Technologie GmbH
    Steinbeis-Forschungszentrum Technologie-Management Nordost
    University of Zurich
    Network for Additive Manufacturing
    BioPortUSA D-A-CH Region
    Business Liaison Desk China
    German-Canadian Centre for Innovation and Research Edmonton/Alberta

    Digital therapy & companions

    Host: Bettine Gola - Berlin Partner für Wirtschaft und Technologie GmbH
    Neomento UiG
    Living Brain GbR
    Dopavision GmbH
    InnoSphere GmbH
    Mindable Health
    Breakthrough GmbH
    Fosanis GmbH
    breazy-health GmbH

    Cooperation track
    13:30 – 14:30
    Hardenberg-Atrium - 1st floor
    Matchmaking Session #1
    Matchmaking
    13:30 – 15:30
    Goldberger Saal - 1st floor
    Serious Games for Health Session

    Drug adherence, changing lifestyle habits, patient interaction or simply acquiring new knowledge can be difficult tasks for every individual. Who hasn’t lost motivation when trying to implement new year’s challenges? However, the issue of adherence and motivation are particularly difficult to steer from a provider’s side.

    In 2003, the World Health Organization estimated that only about 50% of patients with chronic diseases living in developed countries follow treatment recommendations. A 2014 literature review from the Cochrane Library suggests that the figures have not improved.

    Therefore, technologies and ideas from the gaming industry have recently become more and more prominent in the field of life science and healthcare. During this session, we will discover how the knowledge of the gaming industry can be used for medical purposes. The session will have a look into the underlying systematic and new technologies of gaming, showcase three successful examples of gaming in health and leave enough room for discussion of new applications.

    The session is organised in cooperation with media:net berlin-brandenburg and the Hochschule für Technik und Wirtschaft Berlin (HTW, University of Applied Science Berlin).


    Moderator: Martin Steinicke, Hochschule für Technik und Wirtschaft Berlin

    Key note „GAMES“
    Dr. Stefan Göbel, TU-Darmstadt

    Key note “Serious games in healthcare: Opportunities and limits of application by older users”
    Oskar Stamm, Charité Universitätsmedizin Berlin, Working group “Ageing & Technology

    Best Practices
    Jana Frömke, Caterna
    Jana Beyer, IJsfontein Interactive Media GmbH
    Ralph Stock, Serious Games Solutions GmbH

    Discussion with the panel and audience

    Conference
    14:30 – 15:30
    Hardenberg-Atrium - 1st floor
    Matchmaking Session #2
    Matchmaking
    15:30 – 16:30
    Hardenberg-Atrium - 1st floor
    Matchmaking Session #3
    Matchmaking
    16:00 – 18:00
    Goldberger Saal - 1st floor
    Biobased Industries Session

    Rethinking Industries – Biobased Products and Bioeconomy

    Dependence on fossil raw materials is still widely spread throughout the industry. For example, most cars are still running on fossil fuel, plastic is mainly derived from fossil energy carriers and energy itself is mostly generated by nonrenewable resources. But the depletion of these raw materials in the near future, the ambitious goals of minimizing the impact on climate change and findings in various research fields opened the door towards new biobased products. This progress will lead to a more sustainable future and eventually to a biobased economy. Aiming towards higher visibility and raising awareness of the possibilities of biobased industries in the capital region, the session will outline novel biobased products and techniques setting the path towards a biobased economy.

    Welcome address & Introductory remarks

    Key Note
    Dr. Klaus Pellengahr, Organobalance / Novozymes Berlin

    Biopract: The Company between R&D and production

    Dr. Matthias Gerhardt, Biopract GmbH

    Medicines Made from Plants, Air and Light

    Prof. Dr. Peter Seeberger, Max Planck Institute of Colloids and Interfaces

    Cryophilic algae and their potential for a biobased economy

    Dr. Thomas Leya, Fraunhofer-Institute for Cell Therapy and Immunology – Branch Potsdam-Golm (IZI-BB)

    Technological Greenhouse Phase - Ideas Towards Spin-Offs
    Sebastian Müller, Chemical Invention Factory

    Closing remarks

    Conference
    16:00 – 18:00
    Großer Vortragssaal - basement
    Biotech / Pharma Session - in cooperation with CONELIS

    Pharma or Biotech product development is complex and needs a variety of knowledge and experiences. If you do not have the expert needed in-house you can contract specialist support. What are typical assignments and where do you find these experts?

    In this session expert consultants will present real life examples of their work.
    They are members of CONELIS – the Competence Network Life Sciences. CONELIS is an association of selected, independent experts providing top-tier consulting services to the life sciences industry. CONELIS was founded 10 years ago in Berlin.

    Welcome and Introduction

    Sebastian Hillebrand, kasoku Consulting ; Dr. Astrid Schott, Founder and past president of CONELIS e.V.

    Preclinical Projects

    • New drugs, new models! How to test the next breakthrough therapy in oncology (Dr. Jens Hoffmann, Epo Berlin-Buch)
    • Repurposing of a drug approved in the 1990s - pitfall in the nonclinical safety data set (Prof. Matthias Bräutigam Preclinical and Strategy Consultant, Dr. Wolfgang Roßberg, Consult WMR)

    Chemistry Manufacturing and Control

    • Drug substance and drug product – the inevitable hurdles for clinical studies (Prof. Michael Hildebrand, past president of Conelis e.V., Hildebrand Pharma Consulting)

    Intellectual Property

    • Real life example of the benefits of a good patent strategy. (Dr. Sebastian Tegethoff, 24IP Law Group)

    Regulatory affairs and compliance

    • How to achieve quality oversight in virtual companies. (Siglinde (Sigi) Dürr, Quality Consultant)

    Clinical Development

    • Study Design Optimization (Johannes Lampe, Lampe & Company)
    • Preparing a Due Diligence (Carsten Schwenke, SCO:SSIS)
    Conference
    16:30 – 17:30
    Hardenberg-Atrium - 1st floor
    Matchmaking Session #4
    Matchmaking
    17:30 – 18:30
    Hardenberg-Atrium - 1st floor
    Matchmaking Session #5
    Matchmaking
    19:00 – 22:00
    Großer Vortragssaal and Foyer
    Evening reception with Industry Keynote and Speed Lecture Award

    Welcome & Introduction
    Dr. Kai Bindseil, Clustermanager HealthCapital Berlin Brandenburg

    Speed Lectures
    Scientists present their work in a battle for “The Best Science Pitch”
    Moderator: Dr. André Lampe, Scientist, Presenter, Science Communicator     

    Short Welcoming Speech by
    Christian Rickerts, Permanent Secretary at the Senate Department for Economics, Energy and Public Enterprises of the State of Berlin
    Hendrik Fischer, Permanent Secretary at the Ministry for Economic Affairs and Energy of the State of Brandenburg

    Keynote „Healthcare Industries in 2030 – Future Perspective“
    Peter Albiez, Country Manager Pfizer Germany and Spokesman of the Cluster HealthCapital Berlin Brandenburg

    Speed Lecture Award Ceremony
    The winner of the audience voting will be announced

    Get Together

    Conference
    The event agenda's time zone is CEST.